Press Release: NeurAxon : NeurAxon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Report Available

(PR-inside.com) NeurAxon, Inc. (NeurAxon) is a biotechnology company. The company discovers and develops next generation pain therapeutics for the inhibition of neuronal nitric oxide synthase (nNOS). Its products include NXN-188, NXN-462, nNOS/iNOS, nNOS/Opiate and nNOS/NET. NeurAxon's products are used in the treatment of acute migraine, chronic migraine neuropathic pain, inflammatory pain, severe pain and migraine prophylaxis. The company conducts research on nitric oxide and nitric oxide synthase. It has research operations in Ontario, Canada. NeurAxon is headquartered in Mississauga, Ontario, Canada. Full Report Details at - http://www.fastmr.com/prod/1021896_neuraxon_pharmaceuticals.aspx?afid=701 NeurAxon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and ..